Demetrios Kouzoukas, Former Director of the Center for Medicare and Principal Deputy Administrator of CMS, Joins Board of Clo...
April 15 2021 - 9:25AM
Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover”), an
innovative technology company improving health outcomes for
America's seniors, today announced Demetrios L. Kouzakas has joined
its Board of Directors and will serve as a member of the Audit
Committee.
“Clover and the U.S. government have a shared mission of
supporting the health of Medicare beneficiaries and making every
tax dollar as impactful as possible,” said Chief Executive Officer
Vivek Garipalli. “Demetrios is a significant addition to the Board.
Having led the legal and regulatory affairs department of the
Medicare division at UnitedHealth, he understands the opportunity
and challenge of operating at scale. He has an encyclopedic
knowledge of Medicare rules and regulations, combined with an
incredibly astute business and strategy acumen. We are grateful
that Demetrios is joining us on this very important journey.”
For the last four years, until January 2021, Demetrios L.
Kouzoukas served as the Director of the Center for Medicare and the
Principal Deputy Administrator of the Centers for Medicare &
Medicaid Services (CMS). In those roles, he oversaw all operations
and policy development for the Medicare Fee-for-Service Program,
and the Medicare Advantage and Medicare Prescription Drug
Programs.
Prior to joining CMS, from 2012 to 2016, Demetrios served as
General Counsel of UnitedHealthcare’s Medicare & Retirement
division, and prior to that, from 2003 to 2009, he served in the
U.S. Department of Health and Human Services (HHS), where he was
Principal Associate Deputy Secretary, with responsibility for
regulatory policy across HHS, and Deputy General Counsel.
Demetrios has also advised a broad spectrum of entities in the
healthcare system, focusing on evolving regulatory frameworks and
new business models. Demetrios’ expertise in administrative law,
government procedure, and public administration was recognized by
the Administrative Conference of the United States, which appointed
him a Public Member in 2014.
"I’m excited to join the Board because Clover empowers the
physician with its technology, leading to better care coordination
and patient communications. Clover has built its pioneering
business around real-time doctor patient interaction -- and that
opens the door to solving the hardest challenges in healthcare.
Clover’s technology is designed to allow physicians to instantly
address patient needs in an individualized manner by providing
vital health plan resources and benefits beyond what is typically
immediately available to the particular physician or health system.
I believe the sum effect of this will be better care, lower costs
and greater access," said Kouzoukas.
About Clover HealthClover Health (Nasdaq: CLOV)
is a healthcare technology company with a deeply rooted mission of
improving every life. Clover uses its proprietary technology
platform to collect, structure, and analyze health and behavioral
data to improve medical outcomes and lower costs for patients. As a
company whose business goals align with its members' health needs,
Clover works with members and their doctors to become a valued
partner. This trust is built by proactively identifying at-risk
individuals and teaming up with physicians to accelerate care
coordination and simultaneously improve health outcomes and reduce
avoidable costs. Clover has offices in Nashville, San Francisco,
Jersey City and Hong Kong.
Press Contact:Andrew
Still-Baxterpress@cloverhealth.com
Clover Health Investments (NASDAQ:CLOVW)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clover Health Investments (NASDAQ:CLOVW)
Historical Stock Chart
From Sep 2023 to Sep 2024